Vertex, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VERX | XTGLOBAL.BO | NETBAY.BK | TNE.AX | PLUS | CBRAIN.CO | |
|---|---|---|---|---|---|---|
| Market cap | 2.58B | 3.63B | 2.08B | 10.86B | 2.36B | 2.25B |
| P/E (TTM) | 1,592.0 | 31.9 | 10.8 | 77.1 | 19.4 | 49.1 |
| Forward P/E | 15.6 | — | 8.4 | 55.1 | 15.2 | 30.9 |
| Price/book | 9.8 | 2.5 | 5.0 | 25.3 | 2.2 | 7.1 |
| Dividend yield | — | 0.37% | 7.69% | 0.89% | 1.19% | 0.98% |
| 1-year change | −16.65% | −30.88% | −48.00% | −12.67% | +23.31% | −28.49% |
| Today | +4.33% | +0.97% | 0.00% | +5.30% | +0.69% | +12.11% |
The closest companies by business and industry (Software - Application). Prices may be delayed up to 20 min.
Latest news
All VERX news ›Vertex Pharmaceuticals (VRTX) Receives a Buy from TD Cowen
The Globe and Mail In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Vertex Pharmaceuticals, with a price target of $575.00. According to TipRanks, Nadeau is a 4-star analyst with an average return of 6.0% and
Vertex Pharmaceuticals Thrives on Higher Sales and Guidance
Since 2008, Vertex Pharmaceuticals, Inc. (VRTX) shares have received 43 outlier institutional inflow signals and gained over 1,738%. It’s no wonder VRTX shares are up 17% so far this year – and they could rise more. MoneyFlows data shows…
Vertex Reports Third Quarter 2026 Financial Results
— Achieved total revenue of $3.44 billion, a 12% increase compared to third quarter 2025 — — Raising full-year revenue guidance to $13.15 billion to $13.25 billion — — Established fourth commercial pillar in rare endocrine diseases with…
More from 1 other outlet
Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.61% on Nov 3: Drivers Behind the Movement
Vertex Pharmaceuticals Inc (VRTX) moved down by 3.61%. The Pharmaceuticals & Medical Research sector is down by 0.27%. The company underperformed the industry. Top 3 stocks by turnover in the sector: Eli Lilly and Co (LLY) up 0.50%; Pfizer…
Vertex: 3 Key Takeaways for Long-Term Investors
Vertex is betting on nephrology and rare endocrinology to build a fifth and fourth commercial pillar beyond cystic fibrosis. Management extended its patient support program (PSP), which provides software and financial assistance for…
Vertex Pharmaceuticals Incorporated $VRTX Stock Acquired by Vise Technologies Inc.
Posted by Danessa Lincoln on Nov 4th, 2026 NASDAQ:VRTX opened at $530.76 on Wednesday. Vertex Pharmaceuticals Incorporated has a 52 week low of $403.16 and a 52 week high of $568.67. The firm has a 50 day moving average of $522.98 and a…
New SPIRARE II Data at TCT 2026 Show Restoring Normal Pulmonary Pressure Using Vertex™ System Tracked with Right Heart Recovery in Pulmonary Embolism
BioSpace New SPIRARE II Data at TCT 2026 Show Restoring Normal Pulmonary Pressure Using Vertex™ System Tracked with Right Heart Recovery in Pulmonary
UBS maintains Vertex Pharmaceuticals at Buy, raises price target to $640 from $615
UBS maintained Vertex Pharmaceuticals at Buy and raised its price target to $640 from $615, a 4.1% increase. The price target implies an upside of 15.7% from the Nov 2 close of $553.15. Recent analyst actions on Vertex Pharmaceuticals…
How Is Vertex Pharmaceuticals (NASDAQ:VRTX) Expanding Beyond Its Core Business?
S&P 500 Evening Wrap 03-11-2026: Canola Down, ADM In Focus, What Next? What Changes Now That Wells Fargo (NYSE:WFC) Can Expand Again? Beyond acute pain, the same mechanism is being studied in chronic conditions such as nerve-related pain,…
Vertex Pharmaceuticals Incorporated Stock 12‑Month Price Target Raised to $592.56, Implies 7% Upside
TradingView Vertex Pharmaceuticals Incorporated Stock 12‑Month Price Target Raised to $592.56, Implies 7% Upside - According to estimates from 27 analysts, Vertex Pharmaceuticals Incorporated stock'
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com32
- stocktitan.net11
- themarketsdaily.com11
- fool.com10
- seekingalpha.com8
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.